Trial · NCT00715104
Results by group44
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 44
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in the Number of Infiltrating CD3+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Biopsy Benign Tissue | 2.33 | Standard Error 0.34 | cells/μm2 | |
| Change in the Number of Infiltrating CD3+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Benign Tissue | 2.03 | Standard Error 0.19 | cells/μm2 | |
| Change in the Number of Infiltrating CD3+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Tumor Tissue | 1.98 | Standard Error 0.18 | cells/μm2 | |
| Change in the Number of Infiltrating CD3+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Tumor Interface | 6.39 | Standard Error 0.61 | cells/μm2 | |
| Change in the Number of Infiltrating CD4+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Biopsy Benign Tissue | 0.93 | Standard Error 0.24 | cells/μm2 | |
| Change in the Number of Infiltrating CD4+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Benign Tissue | 0.43 | Standard Error 0.09 | cells/μm2 | |
| Change in the Number of Infiltrating CD4+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Tumor Tissue | 0.74 | Standard Error 0.13 | cells/μm2 | |
| Change in the Number of Infiltrating CD4+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Tumor Interface Tissue | 3.83 | Standard Error 0.49 | cells/μm2 | |
| Change in the Number of Infiltrating CD8+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Biopsy Benign Tissue | 0.65 | Standard Error 0.08 | cells/μm2 | |
| Change in the Number of Infiltrating CD8+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Benign Tissue | 0.94 | Standard Error 0.14 | cells/μm2 | |
| Change in the Number of Infiltrating CD8+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Tumor Tissue | 0.88 | Standard Error 0.12 | cells/μm2 | |
| Change in the Number of Infiltrating CD8+ T Cells Within the Prostate Tissue Between the Biopsy and the Post-RP Tissue Specimens in Each Subject | Post-RP Tumor Interface Tissue | 2.87 | Standard Error 0.25 | cells/μm2 | |
| Change in Antigen PA2024-specific T Cell Immunity in Peripheral Blood | Baseline | 4.9 | Standard Error 2.4 | numbers of spots | |
| Change in Antigen PA2024-specific T Cell Immunity in Peripheral Blood | Pre-RP Visit | 56.6 | Standard Error 14.9 | numbers of spots | |
| Change in Antigen PA2024-specific T Cell Immunity in Peripheral Blood | 6 Weeks Post-RP | 26.5 | Standard Error 9.1 | numbers of spots | |
| Change in Antigen PA2024-specific T Cell Immunity in Peripheral Blood | 12 Weeks Post-RP | 52.3 | Standard Error 17.6 | numbers of spots | |
| Change in Antigen PAP-specific T Cell Immunity in Peripheral Blood | Baseline | 2.2 | Standard Error 1.7 | numbers of spots | |
| Change in Antigen PAP-specific T Cell Immunity in Peripheral Blood | Pre-RP Visit | 13.3 | Standard Error 4.9 | numbers of spots | |
| Change in Antigen PAP-specific T Cell Immunity in Peripheral Blood | 6 Weeks Post-RP | 2.0 | Standard Error 1.2 | numbers of spots | |
| Change in Antigen PAP-specific T Cell Immunity in Peripheral Blood | 12 Weeks Post-RP | 12.8 | Standard Error 5.6 | numbers of spots |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00715104/results